Contenu disponible en anglais seulement.
Négociation suspendue de la TSX – Antibe Therapeutics Inc. (ATE)
9 avril 2024
| Issuer: | Antibe Therapeutics Inc. |
| Security: | Common Shares (the "Shares") |
| Symbol(s): | ATE |
| Delisting Review Type: | Expedited |
| Reason: | TSX is reviewing the Shares with respect to meeting the requirements for continued listing pursuant to the Expedited Review Process. |
| Trading: | The Shares are suspended from trading immediately. |
| TSX contact: | Selma Thaver, Managing Director, TSX Listings |
